Back
KBC Group NV Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
86
KBCSY
KBC Group NV
Last Price:
$65.68
Seasonality Move:
2.31%
Sell
45
LYEL
Lyell Immunopharma, Inc.
Last Price:
$31.56
Seasonality Move:
-22.7%
Buy
86
KBC Group NV (KBCSY)
is a Buy
Is KBC Group NV a Buy, Sell or Hold?
-
The current KBC Group NV [KBCSY] share price is $65.68. The Score for KBCSY is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
-
KBCSY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
45
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $31.59. The Score for LYEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KBCSY Stock Price Chart
What is KBC Group NV's stock price today?
-
The KBC Group NV share price today is $65.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KBCSY is experiencing slight selling pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $31.59The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
KBCSY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 66.93 | Buy |
| Chaikin Money Flow: | -597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.66 - 65.44) | Buy |
| Bollinger Bands (100): | (58.3 - 62.82) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | -97541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.36 - 35.26) | Buy |
| Bollinger Bands (100): | (10.99 - 25.97) | Buy |
KBCSY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.56 | Buy |
| 20-day SMA: | 64.1 | Buy |
| 50-day SMA: | 61.98 | Buy |
| 200-day SMA: | 54.63 | Buy |
| 8-day EMA: | 65.39 | Buy |
| 20-day EMA: | 64.34 | Buy |
| 50-day EMA: | 62.42 | Buy |
| 200-day EMA: | 55.33 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Sell |
| 20-day SMA: | 31.47 | Buy |
| 50-day SMA: | 23.56 | Buy |
| 200-day SMA: | 14.09 | Buy |
| 8-day EMA: | 34.44 | Sell |
| 20-day EMA: | 31.53 | Buy |
| 50-day EMA: | 25.65 | Buy |
| 200-day EMA: | 18.32 | Buy |
KBC Group NV Earnings Growth & KBCSY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
KBC Group NV Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||